RGT argent biopharma limited

Analysis of MXC when compared to CPH

  1. 37 Posts.
    lightbulb Created with Sketch. 13

    MXC at time of writing .051 
    CPH at time of writing .54


    Both M pharma companies.

    Both have market cap of 62million


    What really are the differences between these two companies on the books?

    Off the books.. I notice something right away CPH communicates more often then MXC does with announcments.


    CPH 2017 Net loss after tax 3.5million, 2018 7.5 million
    MXC 2017 8.5 million, 2018 8.8 million


    CPH 2017 Revenue 9,639/ 2018 183,654
    MXC 2017 120,242 / 2018 296,811


    CPH 2017 Total Asset 21.6 million / 2018 17.3 million

    MXC 2017 20.8 million / 2018 19.9 million



 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
7.3¢
Change
0.000(0.00%)
Mkt cap ! $5.269M
Open High Low Value Volume
7.3¢ 7.3¢ 7.3¢ $1.339K 18.33K

Buyers (Bids)

No. Vol. Price($)
1 10000 7.4¢
 

Sellers (Offers)

Price($) Vol. No.
7.9¢ 57629 1
View Market Depth
Last trade - 14.07pm 08/08/2025 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.